Amanda Cohn
FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids
The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Oct. 26 endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.